Advertisement
Excessive complement activation contributes to lung disease and adverse patient outcomes
in COVID-19 (see the related research articles by Yan et al. and Ma et al.).
Editorial
Israel's COVID-19 endgame
In-person schooling has proved contentious and difficult to study throughout the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Data from a massive
online survey in the United States indicate an increased risk of COVID-19–related
...
Perspective
Susceptibility to severe COVID-19
Editor's Choice
Anti-body antibodies in COVID-19
A new high-throughput screening technique detected autoantibodies in COVID-19 patients
specific for many different immunomodulatory extracellular and cell surface proteins,
several of which were associated with disease severity and clinical outcomes.
Perspective
COVID-19 and cancer in Africa
Coronavirus disease 2019 (COVID-19) continues to burden society worldwide. Despite
most patients having a mild course, severe presentations have limited treatment options.
COVID-19 manifestations extend beyond the lungs and may affect the cardiovascular,
...
Brazil has been severely hit by COVID-19, with rapid spatial spread of both cases
and deaths. We used daily data on reported cases and deaths to understand, measure,
and compare the spatiotemporal pattern of the spread across municipalities. Indicators
of ...
Editorial
COVID-19 and cancer
Lung transplantation can potentially be a life-saving treatment for patients with
nonresolving COVID-19–associated respiratory failure. Concerns limiting lung transplantation
include recurrence of SARS-CoV-2 infection in the allograft, technical ...
Editorial
Modeling, post COVID-19
Coronavirus disease 2019 (COVID-19) has poorer clinical outcomes in males than in
females, and immune responses underlie these sex-related differences. Because immune
responses are, in part, regulated by metabolites, we examined the serum metabolomes
of ...